ABOUT THIS EPISODE
Join us for a deep dive into hepatocellular carcinoma (HCC) therapy with leaders in the field: Dr. Parissa Tabrizian and Dr. Ju Dong Yang.
In this episode, we break down the modern management of HCC across disease stages, from surgical resection and locoregional therapies to systemic and immunotherapy options. Our guests walk us through real-world clinical decision-making and the nuances of multidisciplinary care in an increasingly complex treatment landscape.
We also feature a special segment at the end with Dr. Allie Cao who is the trainee lead for the HCC Special Interest Group (SIG).
Hosts:
Vlad Fomin
Dilara Hatipoglu
Adam Winters
Alex Vogel
Edited By:
Taylor Gouterman
English
United States
IN THIS EPISODE
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of Liver Talks: The Liver Fellow Network Podcast.
OTHER EPISODES IN THIS PODCAST
On this episode of Liver Talks, Gideon Hirschfield, the Lily and Terry Horner Chair in Autoimmune Liver Disease Research and Professor at the University of Toronto, comes on to talk about the latest advances in primary biliary cholangitis.
Also, we bid Patrick Lee adieu and set the stage for new …
Adam and Alex start by introducing the new fellow lead for Liver Talks, Patrick Lee - a GI fellow at USC. The bulk of the episode is spent discussing a recent paper Adam published about finding your first hepatology job after fellowship. They discuss when and how to apply, what to prioritize, and n…
Enjoy a fantastic talk with the master of portal hypertension, Guadalupe Garcia-Tsao. Perfect for listening whilst in transit to or from San Diego for AASLD!
We are looking for interested trainees to take the reins of fellow lead for Liver Talks next academic year (2025-2026). Feel free to e-ma…
After a respite, Liver Talks is back with a very special guest. We talk to Norah Terrault, Chief of Gastroenterology and Hepatology at Keck Medical Center of USC, about her career, the MASLD nomenclature change, and her work with AASLD. Then, Rob Wilechansky is back to walk us through the latest an…
Big time guest alert!
Dr. Michael Lucey joins us to talk about all things ALD - including early LT and whether or not he uses steroids or steroids + NAC for severe AH. Which is it? You'll have to listen!
Hosts:Patrick LeeAdam Winters @adam_c_wintersAlex Vogel @AlexSVogel
Guests:Michael LuceyRob…
Disclaimer: The podcast and artwork embedded on this page are from Liver Fellow Network, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
